tradingkey.logo
搜索

Biomerica Inc

BMRA
添加自选
1.750USD
-0.020-1.13%
收盘 07/02, 13:00美东报价延迟15分钟
5.30M总市值
亏损市盈率 TTM

Biomerica Inc

1.750
-0.020-1.13%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-1.13%

5天

0.00%

1月

-18.41%

6月

-30.83%

今年开始到现在

-30.56%

1年

-46.48%

关键数据
1.790今开
1.790最高
12.01K成交量
亏损市盈率 TTM
--市盈率动
--股息TTM
0.40%换手率
1.800昨收
1.730最低
19.55K成交额
亏损市盈率静
1.60市净率
0.00%股息率 TTM
-68.12%ROA
4.60052周最高
2.90量比
-4.97M净利润
3.03M总股本
-1.6136每股收益TTM
0.30Beta
-94.32%ROE
1.86652周最低
3.33%振幅
-4.46%毛利率
5.30M总市值
-4.49回报/风险
3.58%风险率

TradingKey Biomerica Inc股票评分

单位: USD 更新时间: 2026-07-02

操作建议

Biomerica Inc当前公司基本面数据相对非常健康,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名161/204位。机构持股占比非常高,中期看,股价处于下降通道。近一个月,市场表现非常差,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Biomerica Inc评分

相关信息

行业排名
161 / 204
全市场排名
485 / 4565
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Biomerica Inc亮点

亮点风险
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
业绩增长期
公司处于发展阶段,最新年度总收入5.31M美元
估值高估
公司最新PE估值-1.08,处于3年历史高位
机构减仓
最新机构持股94.38K股,环比减少72.64%

分析师目标

根据 0 位分析师
--
评级
--
目标均价
--
涨幅空间

Biomerica Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Biomerica Inc简介

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
公司代码BMRA
公司Biomerica Inc
CEOIrani (Zackary S)
网址https://biomerica.com/

常见问题

Biomerica Inc(BMRA)的当前股价是多少?

Biomerica Inc(BMRA)的当前股价是 1.75。

Biomerica Inc的股票代码是什么?

Biomerica Inc的股票代码是BMRA。

Biomerica Inc股票的52周最高点是多少?

Biomerica Inc股票的52周最高点是4.60。

Biomerica Inc股票的52周最低点是多少?

Biomerica Inc股票的52周最低点是1.87。

Biomerica Inc的市值是多少?

Biomerica Inc的市值是5.30M。

Biomerica Inc(BMRA)股票的每股收益(EPS TTM)是多少

Biomerica Inc(BMRA)股票的每股收益(EPS TTM)是-2.16。